ACVR1 and fibrodysplasia ossificans progressiva: Then, we describe very recent findings regarding the potential of anti-ACVR1 antibodies as a therapy for HO in FOP and provide perspective into this somewhat controversial topic while also discussing the unanticipated learnings derived from the corresponding studies.